Key Takeaways
- • Private equity firms have acquired more than 500 autism therapy centers over the past decade, with the majority of deals occurring between 2018 and 2022, capitalizing on Medicaid's high reimbursement rates for Applied Behavior Analysis (ABA) services.
- • State Medicaid payments to autism therapy providers surged to $2.2 billion in 2023, up from $660 million in 2019, representing a 233% increase driven partly by private equity consolidation and aggressive billing practices.
- • Multiple state audits have uncovered consistent patterns of improper billing, compliance failures, and billing issues across PE-backed autism therapy providers, with Colorado auditors identifying at least $77 million in problematic payments.
- • States face intensifying budget pressures as federal Medicaid funding is expected to decline by hundreds of billions over the next decade, while demand for autism services continues rising, creating regulatory and financial scrutiny of PE-dominated providers.
- • Private equity entry into autism therapy is correlated with state Medicaid rates and insurance mandates, according to JAMA research, suggesting PE investment follows high-reimbursement jurisdictions rather than areas with unmet care needs.
Summary
The rapid expansion of private equity into autism therapy services has created a Medicaid funding crisis characterized by rising costs, widespread billing irregularities, and quality-of-care concerns. A new report from the Private Equity Stakeholder Project (PESP) documents that PE firms have acquired more than 500 autism therapy centers over the past decade, with dealmaking concentrated between 2018 and 2022. This consolidation has fundamentally reshaped the industry's cost and payment structure, with direct state Medicaid payments to autism therapy providers surging from $660 million in 2019 to $2.2 billion in 2023—a 233% increase in just four years.
The financial attraction of the sector is clear: states paid an average of $61 per hour for autism therapy services in 2023, with at least one major provider, Piece by Piece Autism Centers, receiving $340,000 in Medicaid payments per patient annually. Research published in JAMA found that PE investment in autism services tracks state Medicaid reimbursement rates and insurance mandate requirements, suggesting that capital follows high-payment jurisdictions rather than areas with greatest clinical need or care gaps.
However, state and federal audits reveal a troubling pattern of billing abuse and oversight failures across PE-backed providers. According to Ryan Leitner, healthcare researcher at PESP, "Private equity firms are using autism therapy as a way to tap into Medicaid dollars. And what we're seeing in audits across multiple states is that it's coming with real problems. The same billing issues and oversight failures are showing up again and again, which raises serious concerns about how this care is being delivered." Colorado auditors identified at least $77 million in improper payments from a single provider, exemplifying the scale of compliance violations across the sector.
The timing of heightened scrutiny coincides with acute state budget pressures. As autism diagnoses among 8-year-olds have climbed to one in 31 as of 2022—from one in 150 in 2000—demand for services has accelerated substantially. Simultaneously, states are preparing for significant federal Medicaid funding reductions expected to exceed hundreds of billions over the next decade under new federal policies. This combination of rising service demand, constrained budgets, and documented billing irregularities is driving regulatory crackdowns and intensifying pressure on state Medicaid programs to control costs and enforce compliance standards.
The financial attraction of the sector is clear: states paid an average of $61 per hour for autism therapy services in 2023, with at least one major provider, Piece by Piece Autism Centers, receiving $340,000 in Medicaid payments per patient annually. Research published in JAMA found that PE investment in autism services tracks state Medicaid reimbursement rates and insurance mandate requirements, suggesting that capital follows high-payment jurisdictions rather than areas with greatest clinical need or care gaps.
However, state and federal audits reveal a troubling pattern of billing abuse and oversight failures across PE-backed providers. According to Ryan Leitner, healthcare researcher at PESP, "Private equity firms are using autism therapy as a way to tap into Medicaid dollars. And what we're seeing in audits across multiple states is that it's coming with real problems. The same billing issues and oversight failures are showing up again and again, which raises serious concerns about how this care is being delivered." Colorado auditors identified at least $77 million in improper payments from a single provider, exemplifying the scale of compliance violations across the sector.
The timing of heightened scrutiny coincides with acute state budget pressures. As autism diagnoses among 8-year-olds have climbed to one in 31 as of 2022—from one in 150 in 2000—demand for services has accelerated substantially. Simultaneously, states are preparing for significant federal Medicaid funding reductions expected to exceed hundreds of billions over the next decade under new federal policies. This combination of rising service demand, constrained budgets, and documented billing irregularities is driving regulatory crackdowns and intensifying pressure on state Medicaid programs to control costs and enforce compliance standards.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.